Increased plasma levels of adrenomedullin in patients with heart failure
Toshio Nishikimi(Kyoto University), Hiroaki Matsuoka(Social Welfare Department), Kenji Kangawa(National Cerebral and Cardiovascular Center), Kazuo Kitamura(University of Miyazaki), Hisayuki Matsuo(National Cerebral and Cardiovascular Center), Teruo Omae(National Cerebral and Cardiovascular Center), Toshihiko Ishimitsu(Dokkyo Medical University), Tanenao Eto(University of Miyazaki), Yoshihiko Saito(National Archives and Records Administration)
Cited by 307
Related Papers
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478